Research output per year
Research output per year
Personal profile
Related documents
Education/Academic qualification
MD, Loma Linda University
… → 1980
BS, Pacific Union College
… → 1977
Disciplines
- Ophthalmology
- Surgery
-
Decoding Scleral Structures with Polarized Light
Chan, C. K. & Henao, M., Apr 18 2024, In: JAMA Ophthalmology. 142, 4, p. 319-320 2 p.Research output: Contribution to journal › Comment/debate › peer-review
-
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials
YOSEMITE and RHINE Investigators, 2024, (Accepted/In press) In: Ophthalmology.Research output: Contribution to journal › Article › peer-review
Open Access -
Long-term Follow-up of a Phase 1/2a Clinical Trial of a Stem Cell-Derived Bioengineered Retinal Pigment Epithelium Implant for Geographic Atrophy
Humayun, M. S., Clegg, D. O., Dayan, M. S., Kashani, A. H., Rahhal, F. M., Avery, R. L., Salehi-Had, H., Chen, S., Chan, C., Palejwala, N., Ingram, A., Mitra, D., Pennington, B. O., Hinman, C., Faynus, M. A., Bailey, J. K., Johnson, L. V. & Lebkowski, J. S., 2024, (Accepted/In press) In: Ophthalmology.Research output: Contribution to journal › Article › peer-review
-
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2
TENAYA and LUCERNE Investigators, 2024, (Accepted/In press) In: Ophthalmology.Research output: Contribution to journal › Article › peer-review
Open Access -
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial
on behalf of the YOSEMITE and RHINE Investigators, May 2023, In: Japanese Journal of Ophthalmology. 67, 3, p. 264-279 16 p.Research output: Contribution to journal › Article › peer-review
Open Access
Activities
- 14 Other